The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 29, 2006

Filed:

May. 06, 2005
Applicants:

Robert J. Altenbach, Chicago, IL (US);

Lawrence A. Black, Libertyville, IL (US);

Sou-jen Chang, Prairie View, IL (US);

Marlon D. Cowart, Round Lake Beach, IL (US);

Ramin Faghih, Lake Forest, IL (US);

Gregory A. Gfesser, Lindenhurst, IL (US);

Yi-yin Ku, Buffalo Grove, IL (US);

Huaqing Liu, Buffalo Grove, IL (US);

Kirill A. Lukin, Mundelein, IL (US);

Diana L. Nersesian, Gurnee, IL (US);

Yu-ming Pu, Gurnee, IL (US);

Michael P. Curtis, Kenosha, WI (US);

Inventors:

Robert J. Altenbach, Chicago, IL (US);

Lawrence A. Black, Libertyville, IL (US);

Sou-Jen Chang, Prairie View, IL (US);

Marlon D. Cowart, Round Lake Beach, IL (US);

Ramin Faghih, Lake Forest, IL (US);

Gregory A. Gfesser, Lindenhurst, IL (US);

Yi-Yin Ku, Buffalo Grove, IL (US);

Huaqing Liu, Buffalo Grove, IL (US);

Kirill A. Lukin, Mundelein, IL (US);

Diana L. Nersesian, Gurnee, IL (US);

Yu-ming Pu, Gurnee, IL (US);

Michael P. Curtis, Kenosha, WI (US);

Assignee:

Abbott Laboratories, Abbott Park, IL (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 31/40 (2006.01); C07D 215/12 (2006.01); C07D 401/04 (2006.01); C07D 207/09 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds of formula (I) wherein Ror Ris an aromatic or non-aromatic ring directly joined or joined by a linker, as represented by Land L, to a heteroaromatic core, and X, X', Y, Y′, Z, Z′, R, R, R, R, R, R, R, L, L, and Lare as defined herein, are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).


Find Patent Forward Citations

Loading…